Variate | 5-year bRFS rate (%) | P value |
---|---|---|
Age (years) | ||
 ≤ 72 | 91.8 | 0.57 |
 > 72 | 93.6 | |
Gleason score | ||
 ≤ 6 | 96.7 | < 0.01 |
 7 | 93.5 | |
 ≥ 8 | 79.3 | |
T stage | ||
 T1–T2b | 94.1 | < 0.01 |
 T2c | 60.0 | |
 ≥ T3 | 69.3 | |
Pretreatment PSA level (mg/dL) | ||
 ≤ 10 | 93.5 | < 0.01 |
 > 10 and ≤ 20 | 95.2 | |
 > 20 | 80.2 | |
D’Amico risk category | ||
 Low risk | 96.9 | < 0.01 |
 Intermediate risk | 93.3 | |
 High risk | 82.0 | |
ADT | ||
 No | 96.6 | < 0.01 |
 Yes | 90.7 |